Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Jul / Coronaviruses and the Common Cold: N Protein Comparisons
Infectious Disease Genetics and epigenetics Microscopy and imaging

Coronaviruses and the Common Cold: N Protein Comparisons

Comparing N protein models and sequence alignments of coronaviruses and the common cold

07/05/2021 Quick Read (pre 2022) 1 min read

Share

“The structures show the comparisons between N protein models for pandemic-related coronaviruses – SARS-CoV-2 (red), Civet (orange), SARS-CoV (tan), MERS (pink) – and common-cold coronaviruses – OC43 (yellow), HKU1 (blue), NL63 (gray), 229E (cyan). For the sequence alignments, our paper (1) defined a new region (~15 amino acids) in the N protein of SARS-CoV-2 where patient antibodies interact. This sequence is 100 percent conserved in all documented patient samples and variants to date. It is also nearly identical in SARS-CoV and Civets. Larger variability is shown in MERS.”

 – Deborah F. Kelly, Professor of Biomedical Engineering and Director of the Center for Structural Oncology at Penn State University.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. MA Casasanta et al., Nanoscale, 13, 7285 (2021). PMID: 33889923.

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Viral Frontier
Infectious Disease
The Viral Frontier

January 23, 2024

1 min read

The latest on the UK COVID-19 inquiry

What’s New in Infectious Disease? (December 2021)
Infectious Disease
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Infectious Disease
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

Pneumocystis Mysteries
Infectious Disease
Pneumocystis Mysteries

January 21, 2022

1 min read

What is the correct name for this pneumonia-causing pathogen?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.